focus -WSS

focus

author：hotspot 2025-10-02 12:02:11 - browse：8533

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Changes to biosimilar regulatory framework must prioritize patients

WSS

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Biotech lab space demand falls sharply

Why the advice to take all your antibiotics may be wrong

Intarcia’s device

CommonSpirit Health keeps growing, even as it loses money

Senate HELP committee spars over health care workforce policies

hotspot

focus

entertainment

Alkermes shareholders re

Lasker Awards 2023: Winners in biomedical research

State Dept. review finds Biden bears some blame for Afghanistan failures

How AI helped researchers track recovery from depression

Medical leaders decry Supreme Court decision on affirmative action

Why the advice to take all your antibiotics may be wrong

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Senate HELP committee spars over health care workforce policies

Hepatitis C has a cure — but many Americans still lack access to it

CommonSpirit Health keeps growing, even as it loses money

hotspot

Experts study whether long Covid risk adds up with each reinfection

Hey, doctors: Don't be no

CDC advisers recommend seasonal use of Pfizer RSV shot

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

STAT Virtual Event: Putting AI to the Test

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

focus

leisure time

Wikipedia

entertainment